CA2028629A1 - Antiandrogenically-effective pharmaceutical compositions - Google Patents

Antiandrogenically-effective pharmaceutical compositions

Info

Publication number
CA2028629A1
CA2028629A1 CA2028629A CA2028629A CA2028629A1 CA 2028629 A1 CA2028629 A1 CA 2028629A1 CA 2028629 A CA2028629 A CA 2028629A CA 2028629 A CA2028629 A CA 2028629A CA 2028629 A1 CA2028629 A1 CA 2028629A1
Authority
CA
Canada
Prior art keywords
antiandrogenically
pharmaceutical compositions
effective pharmaceutical
preparations
effective
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2028629A
Other languages
French (fr)
Other versions
CA2028629C (en
Inventor
Georg Rossling
Andreas Sachse
Jutta Riedl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2028629A1 publication Critical patent/CA2028629A1/en
Application granted granted Critical
Publication of CA2028629C publication Critical patent/CA2028629C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A61Q7/02—Preparations for inhibiting or slowing hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Pharmaceutical preparations are provided comprising antiandrogenically effective substances encapsulated in liposomes. These preparations are preferably used for topical treatment of androgen-dependent diseases.
CA002028629A 1989-10-27 1990-10-26 Antiandrogenically-effective pharmaceutical compositions Expired - Fee Related CA2028629C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP3936328.7 1989-10-27
DE3936328A DE3936328A1 (en) 1989-10-27 1989-10-27 PHARMACEUTICAL PREPARATIONS

Publications (2)

Publication Number Publication Date
CA2028629A1 true CA2028629A1 (en) 1991-04-28
CA2028629C CA2028629C (en) 2000-12-19

Family

ID=6392630

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002028629A Expired - Fee Related CA2028629C (en) 1989-10-27 1990-10-26 Antiandrogenically-effective pharmaceutical compositions

Country Status (15)

Country Link
US (1) US5723146A (en)
EP (1) EP0451237B1 (en)
JP (1) JP3011762B2 (en)
AT (1) ATE103804T1 (en)
AU (1) AU6553790A (en)
CA (1) CA2028629C (en)
DE (2) DE3936328A1 (en)
DK (1) DK0451237T3 (en)
FI (1) FI913100A0 (en)
GR (1) GR900100772A (en)
HU (1) HU215127B (en)
IE (1) IE903859A1 (en)
NO (1) NO912435D0 (en)
PT (1) PT95697B (en)
WO (1) WO1991006284A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6733776B1 (en) * 1992-04-02 2004-05-11 Anticancer, Inc. Method for promoting hair growth
US7556825B2 (en) * 1993-04-02 2009-07-07 Anticancer, Inc. Method for promoting hair growth
US6844326B2 (en) * 1995-06-07 2005-01-18 Anticancer, Inc. Treatment of alopecia
DE19916384A1 (en) * 1999-03-31 2000-10-05 Schering Ag Microparticles useful in treatment of androgen-dependent disorders include biodegradable, synthetic polymers of e.g. polyesters of hydroxycarboxylic acids
JP3466516B2 (en) 1999-09-07 2003-11-10 科学技術振興事業団 Stable oxygen storage solution
EP1316317A1 (en) * 2001-11-30 2003-06-04 University of Liege Hydrosoluble mixtures of cyproterone and/or an ester of it, processes to obtain them and uses thereof
US20030219465A1 (en) * 2002-05-23 2003-11-27 Suresh Kumar Gidwani Composition for delivery of dithranol
US20060165744A1 (en) * 2003-05-22 2006-07-27 Neopharm, Inc Combination liposomal formulations
US20050095283A1 (en) * 2003-09-16 2005-05-05 Aphios Corporation Compositions and methods for topically treating diseases
MX2007002462A (en) * 2004-09-03 2007-10-10 Piedmont Pharmaceuticals Llc Methods for transmembrane treatment and prevention of otitis media.
ZA200803367B (en) * 2005-09-26 2009-09-30 Piedmont Pharmaceuticals Llc Methods for treatment and prevention of otitis media using chemical penetration enhancers to facilitate transmembrane drug delivery into the middle ear
CA2622002A1 (en) * 2005-09-26 2007-04-05 Piedmont Pharmaceuticals Llc Methods for treatment and prevention of otitis media using nonionic surfactants to facilitate transmembrane drug delivery into the middle ear
DE102006062120A1 (en) 2006-12-22 2008-06-26 Grünenthal GmbH Pharmaceutical composition for acne treatment
BRPI0812264B1 (en) * 2007-05-29 2016-01-26 Pola Chem Ind Inc gallbladder and external skin preparation
EA022208B1 (en) * 2008-10-10 2015-11-30 Тева Вимен'С Хелс, Инк. Methods for treating vasomotor symptoms in castrated prostatic cancer patients with low dose cyproterone acetate
ITMI20110644A1 (en) * 2011-04-14 2012-10-15 Giuliani Spa PROLONGED RELEASE SYSTEM FOR COSMETIC AGENTS

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3728364A (en) * 1971-07-27 1973-04-17 Syntex Corp Preparation of 17alpha-propadienyl steroids
GB1570524A (en) * 1976-03-11 1980-07-02 Unilever Ltd Cosmetic
IL64397A0 (en) * 1981-01-07 1982-02-28 Weder Hans G Process for the preparation of liposomal medicaments
US4396615A (en) * 1981-06-24 1983-08-02 Duke University Method of treating androgen-related disorders
DE3279999D1 (en) * 1981-09-30 1989-11-30 Nat Res Dev Compositions comprising encapsulated particles
DE3416978A1 (en) * 1983-05-12 1984-12-06 Stauffer Chemical Co., Westport, Conn. TRANSFORMATION OF EUKARYOTIC CELLS MEDIATED BY LIPOSOME
EP0240630A3 (en) * 1986-04-10 1989-01-25 University Of Miami Treatment of skin of over androgenicity using compositions containing pregnenolone
WO1986001402A1 (en) * 1984-09-05 1986-03-13 Schering Aktiengesellschaft Means for handling androgenization phenomena and use of antiandrogens for the production thereof
IT1199625B (en) * 1985-01-08 1988-12-30 Finchimica Srl THERAPEUTIC USE OF CIPROTERONE ACETATE
FR2619505B1 (en) * 1987-08-20 1990-08-31 Dior Christian Parfums COMPOSITION BASED ON HYDRATED LIPID LAMELLAR PHASES OR LIPOSOMES CONTAINING PREGNENOLONE OR A PREGNENOLONE ESTER, AND COSMETIC OR PHARMACEUTICAL COMPOSITION, IN PARTICULAR DERMATOLOGICAL, WITH REGENERATING OR REVITALIZING ACTIVITY, INCORPORATING
DE3738620A1 (en) * 1987-11-13 1989-05-24 Luderschmidt Christoph USE OF ETHISTERONE FOR TOPICAL TREATMENT OF ACNE OR ANDROGENETIC ALOPECIA
US5110904A (en) * 1989-08-07 1992-05-05 Abbott Laboratories Lhrh analogs

Also Published As

Publication number Publication date
PT95697A (en) 1991-09-13
HUT57590A (en) 1991-12-30
IE903859A1 (en) 1991-05-08
JPH04503676A (en) 1992-07-02
HU907959D0 (en) 1991-11-28
DK0451237T3 (en) 1994-07-18
WO1991006284A1 (en) 1991-05-16
AU6553790A (en) 1991-05-02
FI913100A7 (en) 1991-06-25
CA2028629C (en) 2000-12-19
EP0451237B1 (en) 1994-04-06
US5723146A (en) 1998-03-03
DE59005281D1 (en) 1994-05-11
PT95697B (en) 1997-09-30
HU215127B (en) 1998-09-28
NO912435L (en) 1991-06-21
GR900100772A (en) 1992-03-20
NO912435D0 (en) 1991-06-21
ATE103804T1 (en) 1994-04-15
EP0451237A1 (en) 1991-10-16
FI913100A0 (en) 1991-06-25
DE3936328A1 (en) 1991-05-02
JP3011762B2 (en) 2000-02-21

Similar Documents

Publication Publication Date Title
AU7180387A (en) Topical antimicrobial pharmaceutical compositions and methods
CA2068324A1 (en) Metal-peptide compositions and methods for stimulating hair growth
CA2028629A1 (en) Antiandrogenically-effective pharmaceutical compositions
AU590403B2 (en) Pharmaceutical composition for the treatment of periodontal diseases
AU6974191A (en) Stable cream and lotion bases for lipophilic drug compositions
FI903382A7 (en) Topically administered pharmaceutical preparations
AU1795383A (en) Pharmaceutical preparations having analgetic and cytostatic activity
AU5561690A (en) Improvements in or relating to pharmaceutical preparations
IT1240473B (en) PROCEDURE TO IMPROVE THE THERAPEUTIC EFFICACY OF LIPOSOLUBLE CORTICOSTEROIDS AND COMPOSITION FOR THE IMPLEMENTATION OF SUCH PROCEDURE
IT1224574B (en) ACTUATION FACTOR OF NEUTROFILE LEUKOCYTES, PREPARATION PROCEDURE, AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT
AU3760789A (en) Topical cosmetic and pharmaceutical preparation
HUT49370A (en) Process for producing polypeptides and pharmaceutical compositions comprising same as active ingredient
HUT46660A (en) Process for producing 3-alkoxy-2-amino-propyl-amines and pharmaceutical compositions comprising the same as active ingredient
IL105000A0 (en) Imidazolyl-substituted phenylacetamides,their preparation and pharmaceutical compositions containing them
AU5252090A (en) Improvements in and relating to pharmaceutical formulations
IL117078A0 (en) Substituted benzenesulfonylureas and -thioureas processes for their preparation their use for the production of pharmaceutical preparations and pharmaceutical preparations containing them
IL82726A (en) Pharmaceutical compositions comprising anticonvulsively active 1-phenalkylimidazole-4-and/or-5-carboxamides and certain novel phenalkylimidazoles and their manufacture
ZA961314B (en) Substituted benzenesulfonylureas and -thioreas processes for their preparation their use for the production of pharmaceutical preparations and medicaments containing them
AU6236090A (en) Pharmaceutical preparations
HUT49112A (en) Process for producing new 1-aryloxy-3-amino-2-propanols and pharmaceutical compositions comprising such active ingredient
IL95142A0 (en) 2-amino-7-carbamoyl-1,2,3,4-tetrahydronaphthalenes,their preparation and pharmaceutical compositions containing them
AU625769B2 (en) 2-ethoxymethyl-5-hydroxy-gamma-pyrone and melanogenesis- inhibiting endermic preparation containing the same compound as active ingredient
AU6271490A (en) Anti-inflammatory active ingredients for cosmetic preparations
AU7279887A (en) Aluminium-hydrogen-oxygen complex and pharmaceutical/cosmetic compositions thereof
IL94084A0 (en) Naphthalenyl-3h-1,2,3,5-oxathiazole 2-oxides,their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed